Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

OBJECTIVE: Many patients receiving dual antiplatelet therapy still had recurrent strokes. We aimed to identify factors associated with recurrent stroke at 90 days in patients receiving dual antiplatelet therapy in Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangqin, Runqi, Wang, Xianwei, Wang, Yilong, Xian, Ying, Zhao, Xingquan, Liu, Liping, Li, Hao, Meng, Xia, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829906/
https://www.ncbi.nlm.nih.gov/pubmed/29507777
http://dx.doi.org/10.1136/svn-2017-000088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829906/
https://www.ncbi.nlm.nih.gov/pubmed/29507777
http://dx.doi.org/10.1136/svn-2017-000088

Ejemplares similares